Edmondson Editorial on Impact of Sarbanes-Oxley in Risk & Compliance Magazine
21 March 2017
Partner Joseph Edmondson wrote an editorial that was published in the January-March 2017 issue of Risk & Compliance Magazine titled “Reporting-Out Under Sarbanes-Oxley: Have the Worst Fears of Attorneys Been Realised?” His editorial discusses the impact that a Sarbanes-Oxley provision and a Securities and Exchange Commission (SEC) Rule has had on attorneys appearing and practicing before the SEC.
Main topics covered within the article include ethics of confidentiality versus not participating in the assistance of a client’s fraud, and the SEC’s requirements for attorneys.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”